特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
956939

気道浄化システムの世界市場

Airway Clearance Systems

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 229 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.59円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

気道浄化システムの世界市場
出版日: 2020年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 229 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の気道浄化システムの市場規模は、分析期間(2020年~2027年)に6.2%のCAGRで成長する見通しで、2020年の5億2,210万米ドルから2027年には7億9,340万米ドルに達すると予測されています。当レポートで分析されているセグメントの1つである呼気陽圧 (PEP) は、分析期間中に5.9%の年率で成長し、4億1,430万米ドルに達すると予測されています。

当レポートは、世界の気道浄化システム市場について調査しており、市場シェア、動向や見通し、成長要因、地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

調査対象企業の例

  • Electromed, Inc.
  • General Physiotherapy, Inc.
  • Hill-Rom Holdings, Inc.
  • Monaghan Medical Corporation
  • Philips Healthcare
  • Thayer Medical
  • Vortran Medical Technology

目次

I. イントロダクション、調査手法 、 調査範囲

II. エグゼクティブサマリー

  • 市場概要
    • 競合の市場シェア
    • 競合の市場シェアシナリオ
    • Covid-19の影響と迫り来る世界の景気後退
  • 主要企業
  • 動向と成長要因
  • 世界市場の見通し

III. 市場分析

  • 地域別市場分析
  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

IV. 競合

  • 企業プロファイル:46社
目次
Product Code: MCP10221

Global Airway Clearance Systems Market to Reach $793.4 Million by 2027

Amid the COVID-19 crisis, the global market for Airway Clearance Systems estimated at US$522.1 Million in the year 2020, is projected to reach a revised size of US$793.4 Million by 2027, growing at a CAGR of 6.2% over the analysis period 2020-2027. Positive Expiratory Pressure (PEP), one of the segments analyzed in the report, is projected to record a 5.9% CAGR and reach US$414.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Oscillatory Positive Expiratory Pressure (OPEP) segment is readjusted to a revised 6.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $154 Million, While China is Forecast to Grow at 5.8% CAGR

The Airway Clearance Systems market in the U.S. is estimated at US$154 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$139.6 Million by the year 2027 trailing a CAGR of 5.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 4.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Other Device Types Segment to Record 5.4% CAGR

In the global Other Device Types segment, USA, Canada, Japan, China and Europe will drive the 5.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$43.6 Million in the year 2020 will reach a projected size of US$63.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$91.5 Million by the year 2027.We bring years of research experience to this 9th edition of our report. The 229-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Electromed, Inc.
  • General Physiotherapy, Inc.
  • Hill-Rom Holdings, Inc.
  • Monaghan Medical Corporation
  • Philips Healthcare
  • Thayer Medical
  • Vortran Medical Technology

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Competitor Market Shares
    • Airway Clearance Systems Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Airway Clearance Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 2: World Historic Review for Airway Clearance Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 3: World 15-Year Perspective for Airway Clearance Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Positive Expiratory Pressure (PEP) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 5: World Historic Review for Positive Expiratory Pressure (PEP) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 6: World 15-Year Perspective for Positive Expiratory Pressure (PEP) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Oscillatory Positive Expiratory Pressure (OPEP) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 8: World Historic Review for Oscillatory Positive Expiratory Pressure (OPEP) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 9: World 15-Year Perspective for Oscillatory Positive Expiratory Pressure (OPEP) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 11: World Historic Review for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 12: World 15-Year Perspective for Other Device Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Cystic Fibrosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 14: World Historic Review for Cystic Fibrosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 15: World 15-Year Perspective for Cystic Fibrosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Chronic Bronchitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 17: World Historic Review for Chronic Bronchitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 18: World 15-Year Perspective for Chronic Bronchitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 20: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 21: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 23: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 24: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 26: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 27: World 15-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 29: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 30: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Airway Clearance Systems Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 31: USA Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 32: USA Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 33: USA 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 34: USA Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 35: USA Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 36: USA 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 37: USA Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 38: USA Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 39: USA 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 40: Canada Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 41: Canada Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 42: Canada 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 43: Canada Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 44: Canada Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 45: Canada 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 46: Canada Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 47: Canada Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 48: Canada 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 49: Japan Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 50: Japan Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 51: Japan 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 52: Japan Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 53: Japan Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 54: Japan 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 55: Japan Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 56: Japan Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 57: Japan 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 58: China Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 59: China Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 60: China 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 61: China Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 62: China Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 63: China 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 64: China Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 65: China Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 66: China 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • EUROPE
    • Market Facts & Figures
    • European Airway Clearance Systems Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • Market Analytics
    • TABLE 67: Europe Current & Future Analysis for Airway Clearance Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 68: Europe Historic Review for Airway Clearance Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 69: Europe 15-Year Perspective for Airway Clearance Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 70: Europe Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 71: Europe Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 72: Europe 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 73: Europe Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 74: Europe Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 75: Europe 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 76: Europe Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 77: Europe Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 78: Europe 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 79: France Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 80: France Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 81: France 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 82: France Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 83: France Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 84: France 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 85: France Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 86: France Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 87: France 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 88: Germany Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 89: Germany Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 90: Germany 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 91: Germany Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 92: Germany Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 93: Germany 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 94: Germany Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 95: Germany Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 96: Germany 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 97: Italy Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 98: Italy Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 99: Italy 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 100: Italy Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 101: Italy Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 102: Italy 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 103: Italy Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 104: Italy Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 105: Italy 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 106: UK Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 107: UK Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 108: UK 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 109: UK Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 110: UK Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 111: UK 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 112: UK Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 113: UK Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 114: UK 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 115: Rest of Europe Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 116: Rest of Europe Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 117: Rest of Europe 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 118: Rest of Europe Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 119: Rest of Europe Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 120: Rest of Europe 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 121: Rest of Europe Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 122: Rest of Europe Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 123: Rest of Europe 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 124: Asia-Pacific Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 125: Asia-Pacific Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 126: Asia-Pacific 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 127: Asia-Pacific Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 128: Asia-Pacific Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 129: Asia-Pacific 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 130: Asia-Pacific Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 131: Asia-Pacific Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 132: Asia-Pacific 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 133: Rest of World Current & Future Analysis for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 134: Rest of World Historic Review for Airway Clearance Systems by Device Type - Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 135: Rest of World 15-Year Perspective for Airway Clearance Systems by Device Type - Percentage Breakdown of Value Sales for Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP) and Other Device Types for the Years 2012, 2020 & 2027
    • TABLE 136: Rest of World Current & Future Analysis for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 137: Rest of World Historic Review for Airway Clearance Systems by Application - Cystic Fibrosis, Chronic Bronchitis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 138: Rest of World 15-Year Perspective for Airway Clearance Systems by Application - Percentage Breakdown of Value Sales for Cystic Fibrosis, Chronic Bronchitis and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 139: Rest of World Current & Future Analysis for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 140: Rest of World Historic Review for Airway Clearance Systems by End-Use - Hospitals & Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 141: Rest of World 15-Year Perspective for Airway Clearance Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Settings and Other End-Uses for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 46
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.